China Biologic Products, Inc. 4
4 · China Biologic Products, Inc. · Filed Sep 16, 2015
Insider Transaction Report
Form 4
Yang Ming
Interim CFO
Transactions
- Sale
Common stock
2015-09-14$97.08/sh−11,304$1,097,392→ 24,782 total - Exercise/Conversion
Common stock
2015-09-14$9.85/sh+1,000$9,850→ 36,086 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-14−1,000→ 49,000 totalExercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (1,000 underlying) - Sale
Common stock
2015-09-15$94.56/sh−9,000$851,040→ 24,782 total - Exercise/Conversion
Stock Option (right to buy)
2015-09-15−9,000→ 40,000 totalExercise: $9.85From: 2013-09-01Exp: 2022-08-31→ Common stock (9,000 underlying) - Exercise/Conversion
Common stock
2015-09-15$9.85/sh+9,000$88,650→ 33,782 total
Footnotes (8)
- [F1]Represents 1,000 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 6 below for further details on the relevant stock options.
- [F2]Represents 11,304 shares of common stock (the "September 14 Sold Common Stock") sold on the open market at a weighted average price of $97.08 per share on September 14, 2015. The September 14 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 1,000 shares of the Issuer's common stock and vesting of 10,304 restricted stocks.
- [F3]Represents 9,000 shares of common stock (the "September 15 Sold Common Stock") sold on the open market at a weighted average price of $94.56 per share on September 15, 2015. The September 15 Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase 9,000 shares of the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $93.70 to $100.50, inclusive. The Reporting Person undertakes to provide to any security holders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 4 and Footnote 5 to this Form 4.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $94.00 to $95.54, inclusive.
- [F6]Represents previously reported stock options to purchase 1,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- [F7]Represents previously reported stock options to purchase 9,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were scheduled to vest in four equal portions on a quarterly basis over a four-year period, with the initial vesting date being September 1, 2013, provided that the Reporting Person is employed by the Issuer on each vesting date.
- [F8]Includes the balance of the previously reported stock options to purchase 50,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012.